SERIAL INNOVATOR, EITAN KONSTANTINO JOINS GENESIS MEDTECH AS CTO OF THE VASCULAR INTERVENTIONS FRANCHISE

0

SINGAPORE, January 7, 2022 / PRNewswire / – Genesis MedTech Group (Genesis or Group) has appointed Dr. Eitan Konstantino (Eitan) as Technical Director of Vascular Interventions to propel Genesis’ technological innovation in the neurovascular, cardiovascular and peripheral vascular spaces. His role will include developing and implementing the Group’s global R&D strategy for vascular interventions, improving R&D capabilities and products, and ensuring the execution and management of major projects. of R&D. The objective is to stimulate the development of innovation and to develop the Group’s product portfolio.

Eitan has a stellar track record of over 20 years in the MedTech arena, notably defined by many groundbreaking inventions. He has built his reputation by inventing and developing stents, special angioplasty balloons (AngioSculpt and Chocolate® among others), nitinol vascular devices and drug / device combination products. Its products have since been acquired or distributed by large multinational companies, including Medtronic, Teleflex, Philips and Boston Scientific. These products are now commercially available from most hospitals in United States and generated cumulative revenues of nearly $ 1 billion.

Currently, Eitan holds more than 170 US and international patents and patent applications. Eitan holds a PhD in Mechanical Engineering from Technion, Israel Institute of Technology. While at the Technion, he received the Rothschild Creativity Award and the Schwartz Outstanding Achievement Award.

Speaking from its current base at California, Eitan said, “I am delighted to join Genesis’ vision of a differentiated, patient-centric healthcare platform, creating innovative products that are more accessible to all. I look forward to establishing a global innovation ecosystem to support Genesis’ rapidly growing commercial presence. “

In a similar agreement, Warren wang, CEO of Genesis MedTech Group said, “Eitan has a proven track record as a serial innovator who can apply entrepreneurial mindsets to improve healthcare solutions for patients. With its membership, we will be in a better position to take a unified global approach to R&D, harnessing regional talents and strengths to advance and accelerate technological innovation in our current product portfolio. This will help establish Genesis as a differentiated innovator who develops high quality, innovative solutions that are made accessible to more patients.

ABOUT GENESIS MEDTECH GROUP

Genesis MedTech Group is a medical device company based in Singapore. Founded by a group of professionals and entrepreneurs with MedTech experience globally and in Asia, the company’s product portfolio focuses on value segment multi-therapy medical device products for emerging markets with sales and distribution through its established sales network. Genesis MedTech Group covers the entire industry value chain from research and development, production, quality management, supply chain, marketing and sales.

For more information visit http://www.genesismedtech.com.

SOURCE Genesis MedTech


Source link

Share.

Comments are closed.